PNGM — Er Therapeutics Cashflow Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro Cap

Annual cashflow statement for Er Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2006 November 30th	2007 November 30th	2008 November 30th	2009 November 30th	2010 November 30th
Period Length:	7 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.02	-0.108	-0.139	-0.376	-0.427
Depreciation
Non-Cash Items	—	0	0.006	0.063	0.071
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.007	0.017	0.091	0.108	0.195
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities	-0.027	-0.091	-0.042	-0.204	-0.161
Capital Expenditures	-0.006	-0.002	0	-0.01	-0.068
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	0	-0.11	0.1	0.117
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-0.006	-0.002	-0.11	0.09	0.049
Financing Cash Flow Items	—	0	0.001	0.003	-0.005
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.129	0	0.178	0.088	0.109
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.096	-0.093	0.026	-0.026	-0.003